Osteoporosis under psychological stress: mechanisms and therapeutics

Abstract

Psychological stress has been associated with the onset of several diseases, including osteoporosis. However, the underlying pathogenic mechanism remains unknown, and effective therapeutic strategies are still unavailable. Growing evidence suggests that the sympathetic nervous system regulates bone homeostasis and vascular function under psychological stress, as well as the coupling of osteogenesis and angiogenesis in bone development, remodeling, and regeneration. Furthermore, extracellular vesicles (EVs), particularly mesenchymal stem cell extracellular vesicles (MSC–EVs), have emerged as prospecting therapies for stimulating angiogenesis and bone regeneration. We summarize the role of sympathetic regulation in bone homeostasis and vascular function in response to psychological stress and emphasize the relationship between vessels and bone. Finally, we suggest using MSC–EVs as a promising therapeutic method for treating osteoporosis in psychological stress.

Keywords

psychological stress / osteoporosis / sympathetic nervous system / type H vessels / extracellular vesicles

References

[1] Baum A. Stress, intrusive imagery, and chronic distress. Health Psychol 1990;9:653–75.

[2] Willmore L, Cameron C, Yang J, et al. Behavioural and dopaminergic signatures of resilience. Nature 2022;611:124–32.

[3] Woolston C. Stress and uncertainty drag down graduate students’ satisfaction. Nature 2022;610:805–8.

[4] Haslam C, Haslam SA, Jetten J, et al. Life change, social identity, and health. Annu Rev Psychol 2021;72:635–61.

[5] Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA 2007;298:1685–7.

[6] Baron KG, Reid KJ. Circadian misalignment and health. Int Rev Psychiatry 2014;26:139–54.

[7] Biddie SC, Conway-Campbell BL, Lightman SL. Dynamic regulation of glucocorticoid signalling in health and disease. Rheumatology 2012;51:403–12.

[8] Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol 2009;5:374–81.

[9] Cruz-Pereira JS, Rea K, Nolan YM, et al. Depression’s unholy trinity: dysregulated stress, immunity, and the microbiome. Annu Rev Psychol 2020;71:49–78.

[10] De Kloet ER, Vreugdenhil E, Oitzl MS, et al. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998;19:269–301.

[11] Miller GE, Cohen S, Ritchey AK. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 2002;21:531–41.

[12] Potter GD, Skene DJ, Arendt J, et al. Circadian rhythm and sleep disruption: Causes, metabolic consequences, and countermeasures. Endocr Rev 2016;37:584–608.

[13] Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet 2019;393:364–76.

[14] Sarafrazi N, Wambogo EA, Shepherd JA. Osteoporosis or low bone mass in older adults: United States, 2017-2018. NCHS Data Brief 2021;405:1–8.

[15] Ng JS, Chin KY. Potential mechanisms linking psychological stress to bone health. Int J Med Sci 2021;18:604–14.

[16] Bab I, Yirmiya R. Depression, selective serotonin reuptake inhibitors, and osteoporosis. Curr Osteoporos Rep 2010;8:185–91.

[17] Erez HB, Weller A, Vaisman N, et al. The relationship of depression, anxiety and stress with low bone mineral density in post-menopausal women. Arch Osteoporos 2012;7:247–55.

[18] Cizza G, Primma S, Csako G. Depression as a risk factor for osteoporosis. Trends Endocrinol Metab 2009;20:367–73.

[19] Pedersen AB, Baggesen LM, Ehrenstein V, et al. Perceived stress and risk of any osteoporotic fracture. Osteoporos Int 2016;27:2035–45.

[20] El-Gabalawy R, Blaney C, Tsai J, et al. Physical health conditions associated with full and subthreshold PTSD in U.S. military veterans: Results from the National Health and Resilience in Veterans Study. J Affect Disord 2018;227:849–53.

[21] Rauma PH, Honkanen RJ, Williams LJ, et al. Effects of antidepressants on postmenopausal bone loss – A 5-year longitudinal study from the OSTPRE cohort. Bone 2016;89:25–31.

[22] Russell G, Lightman S. The human stress response. Nat Rev Endocrinol 2019;15:525–34.

[23] O’Connor DB, Thayer JF, Vedhara K. Stress and health: a review of psychobiological processes. Annu Rev Psychol 2021;72:663–88.

[24] al’Absi M, Wittmers LE, Jr. Enhanced adrenocortical responses to stress in hypertension-prone men and women. Ann Behav Med 2003;25:25–33.

[25] Adam EK, Quinn ME, Tavernier R, et al. Diurnal cortisol slopes and mental and physical health outcomes: a systematic review and meta-analysis. Psychoneuroendocrinology 2017;83:25–41.

[26] McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998;338:171–9.

[27] Espinosa-Medina I, Saha O, Boismoreau F, et al. The sacral autonomic outflow is sympathetic. Science 2016;354:893–7.

[28] Elefteriou F. Impact of the autonomic nervous system on the skeleton. Physiol Rev 2018;98:1083–112.

[29] Tourtellotte WG. Axon transport and neuropathy: relevant perspectives on the etiopathogenesis of familial dysautonomia. Am J Pathol 2016;186:489–99.

[30] Hasan W. Autonomic cardiac innervation: development and adult plasticity. Organogenesis 2013;9:176–93.

[31] Goldstein DS, Robertson D, Esler M, et al. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 2002;137:753–63.

[32] Saravia F, Homo-Delarche F. Is innervation an early target in autoimmune diabetes? Trends Immunol 2003;24:574–9.

[33] Hanoun M, Maryanovich M, Arnal-Estape A, et al. Neural regulation of hematopoiesis, inflammation, and cancer. Neuron 2015;86:360–73.

[34] Karsenty G, Olson EN. Bone and muscle endocrine functions: unexpected paradigms of inter-organ communication. Cell 2016;164:1248–56.

[35] Cappariello A, Ponzetti M, Rucci N. The “soft” side of the bone: unveiling its endocrine functions. Horm Mol Biol Clin Investig 2016;28:5–20.

[36] Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197–207.

[37] Sato S, Hanada R, Kimura A, et al. Central control of bone remodeling by neuromedin U. Nat Med 2007;13:1234–40.

[38] Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 2002;58:77–84.

[39] Asmus SE, Parsons S, Landis SC. Developmental changes in the transmitter properties of sympathetic neurons that innervate the periosteum. J Neurosci 2000;20:1495–504.

[40] Nagata A, Tanaka T, Minezawa A, et al. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells. J Cell Physiol 2009;221:75–83.

[41] Sims NA, Martin TJ. Coupling signals between the osteoclast and osteoblast: How are messages transmitted between these temporary visitors to the bone surface? Front Endocrinol 2015;6:41.

[42] Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet 2011;377:1276–87.

[43] Yao Q, Liang H, Huang B, et al. Beta-adrenergic signaling affect osteoclastogenesis via osteocytic MLO-Y4 cells’ RANKL production. Biochem Biophys Res Commun 2017;488:634–40.

[44] Ma Y, Nyman JS, Tao H, et al. beta2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone. Endocrinology 2011;152:1412–22.

[45] Kondo A, Mogi M, Koshihara Y, et al. Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem Pharmacol 2001;61:319–26.

[46] Yahara M, Tei K, Tamura M. Inhibition of neuropeptide Y Y1 receptor induces osteoblast differentiation in MC3T3-E1 cells. Mol Med Rep 2017;16:2779–84.

[47] Wee NKY, Sinder BP, Novak S, et al. Skeletal phenotype of the neuropeptide Y knockout mouse. Neuropeptides 2019;73:78–88.

[48] Hu CH, Sui BD, Liu J, et al. Sympathetic neurostress drives osteoblastic exosomal MiR-21 transfer to disrupt bone homeostasis and promote osteopenia. Small Methods 2022;6:e2100763.

[49] Sui B, Liu J, Zheng C, et al. Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress. Int J Oral Sci 2022;14:39.

[50] Elefteriou F, Ahn JD, Takeda S, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005;434:514–20.

[51] Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res 1967;11:213–8.

[52] McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007;87:873–904.

[53] Wirtz PH, von Kanel R. Psychological stress, inflammation, and coronary heart disease. Curr Cardiol Rep 2017;19:111.

[54] Antelman SM, DeGiovanni LA, Kocan D. A single exposure to cocaine or immobilization stress provides extremely long-lasting, selective protection against sudden cardiac death from tetracaine. Life Sci 1989;44:201–7.

[55] Van Dijken HH, Van der Heyden JA, Mos J, et al. Inescapable foot-shocks induce progressive and long-lasting behavioural changes in male rats. Physiol Behav 1992;51:787–94.

[56] Pynoos RS, Ritzmann RF, Steinberg AM, et al. A behavioral animal model of posttraumatic stress disorder featuring repeated exposure to situational reminders. Biol Psychiatry 1996;39:129–34.

[57] Siegmund A, Wotjak CT. A mouse model of posttraumatic stress disorder that distinguishes between conditioned and sensitised fear. J Psychiatr Res 2007;41:848–60.

[58] Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11:47–60.

[59] Richter-Levin G. Acute and long-term behavioral correlates of underwater trauma—potential relevance to stress and post-stress syndromes. Psychiatry Res 1998;79:73–83.

[60] Balkaya M, Prinz V, Custodis F, et al. Stress worsens endothelial function and ischemic stroke via glucocorticoids. Stroke 2011;42:3258–64.

[61] Gameiro GH, Gameiro PH, Andrade Ada S, et al. Nociception- and anxiety-like behavior in rats submitted to different periods of restraint stress. Physiol Behav 2006;87:643–9.

[62] Nakajima K, Hamada N, Takahashi Y, et al. Restraint stress enhances alveolar bone loss in an experimental rat model. J Periodontal Res 2006;41:527–34.

[63] Takeda O, Toyama T, Watanabe K, et al. Ameliorating effects of Juzentaihoto on restraint stress and P. gingivalis-induced alveolar bone loss. Arch Oral Biol 2014;59:1130–8.

[64] Liberzon I, Krstov M, Young EA. Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology 1997;22:443–53.

[65] Adamec RE, Shallow T. Lasting effects on rodent anxiety of a single exposure to a cat. Physiol Behav 1993;54:101–9.

[66] Zoladz PR, Conrad CD, Fleshner M, et al. Acute episodes of predator exposure in conjunction with chronic social instability as an animal model of post-traumatic stress disorder. Stress 2008;11:259–81.

[67] Zhang J, Fujita Y, Chang L, et al. Beneficial effects of anti-RANKL antibody in depression-like phenotype, inflammatory bone markers, and bone mineral density in male susceptible mice after chronic social defeat stress. Behav Brain Res 2020;379:112397.

[68] Hammamieh R, Chakraborty N, De Lima TC, et al. Murine model of repeated exposures to conspecific trained aggressors simulates features of post-traumatic stress disorder. Behav Brain Res 2012;235:55–66.

[69] Pibiri F, Nelson M, Guidotti A, et al. Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder. Proc Natl Acad Sci U S A 2008;105:5567–72.

[70] Mountain RV, Langlais AL, Hu D, et al. Social isolation through single housing negatively affects trabecular and cortical bone in adult male, but not female, C57BL/6J mice. Bone 2023;172:116762.

[71] Patki G, Solanki N, Salim S. Witnessing traumatic events causes severe behavioral impairments in rats. Int J Neuropsychopharmacol 2014;17:2017–29.

[72] Ardi Z, Albrecht A, Richter-Levin A, et al. Behavioral profiling as a translational approach in an animal model of posttraumatic stress disorder. Neurobiol Dis 2016;88:139–47.

[73] Kalinichev M, Easterling KW, Plotsky PM, et al. Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long-Evans rats. Pharmacol Biochem Behav 2002;73:131–40.

[74] Bertolini Botelho MC, Cintra LTA, da Silva CC, et al. Early life stress exacerbates bone resorption and inhibits anxiety-like behaviour induced by apical periodontitis in rats. Int Endod J 2023;56:203–12.

[75] Steru L, Chermat R, Thierry B, et al. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985;85:367–70.

[76] Hu Y, Zhang Y, Ni CY, et al. Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism. Theranostics 2020;10:2293–308.

[77] Reber SO, Birkeneder L, Veenema AH, et al. Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: implications and mechanisms. Endocrinology 2007;148:670–82.

[78] Xie X, Shen Q, Yu C, et al. Depression-like behaviors are accompanied by disrupted mitochondrial energy metabolism in chronic corticosterone-induced mice. J Steroid Biochem Mol Biol 2020;200:105607.

[79] Fetcho RN, Hall BS, Estrin DJ, et al. Regulation of social interaction in mice by a frontostriatal circuit modulated by established hierarchical relationships. Nat Commun 2023;14:2487.

[80] Francois M, Canal Delgado I, Shargorodsky N, et al. Assessing the effects of stress on feeding behaviors in laboratory mice. Elife 2022;11:e70271.

[81] Lee EH, Park JY, Kwon HJ, et al. Repeated exposure with short-term behavioral stress resolves pre-existing stress-induced depressive-like behavior in mice. Nat Commun 2021;12:6682.

[82] Liu MY, Yin CY, Zhu LJ, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc 2018;13:1686–98.

[83] Shi X, Gao Y, Song L, et al. Sulfur dioxide derivatives produce antidepressant- and anxiolytic-like effects in mice. Neuropharmacology 2020;176:108252.

[84] Sui B, Hu C, Liao L, et al. Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesis. Sci Rep 2016;6:30186.

[85] Young BE, Holwerda SW, Vranish JR, et al. Sympathetic transduction in type 2 diabetes mellitus. Hypertension 2019;74:201–7.

[86] Rana T, Schultz MA, Freeman ML, et al. Loss of Nrf2 accelerates ionizing radiation-induced bone loss by upregulating RANKL. Free Radic Biol Med 2012;53:2298–307.

[87] Filipowska J, Tomaszewski KA, Niedzwiedzki L, et al. The role of vasculature in bone development, regeneration and proper systemic functioning. Angiogenesis 2017;20:291–302.

[88] Maes C, Carmeliet G, Schipani E. Hypoxia-driven pathways in bone development, regeneration and disease. Nat Rev Rheumatol 2012;8:358–66.

[89] Clarkin C, Olsen BR. On bone-forming cells and blood vessels in bone development. Cell Metab 2010;12:314–6.

[90] Duan X, Murata Y, Liu Y, et al. Vegfa regulates perichondrial vascularity and osteoblast differentiation in bone development. Development 2015;142:1984–91.

[91] Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 2014;507:323–8.

[92] Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17–29.

[93] Langen UH, Pitulescu ME, Kim JM, et al. Cell-matrix signals specify bone endothelial cells during developmental osteogenesis. Nat Cell Biol 2017;19:189–201.

[94] Watson EC, Adams RH. Biology of bone: the vasculature of the skeletal system. Cold Spring Harb Perspect Med 2018;8:a031559.

[95] Burnstock G. Local mechanisms of blood flow control by perivascular nerves and endothelium. J Hypertens Suppl 1990;8:S95–106.

[96] Godo S, Shimokawa H. Endothelial functions. Arterioscler Thromb Vasc Biol 2017;37:e108–14.

[97] Tesfamariam B, Weisbrod RM, Cohen RA. Endothelium inhibits responses of rabbit carotid artery to adrenergic nerve stimulation. Am J Physiol 1987;253:H792–798.

[98] Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001;53:319–56.

[99] Luscher TF, Yang Z, Tschudi M, et al. Interaction between endothelin- 1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 1990;66:1088–94.

[100] Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011;146:873–87.

[101] Makanya AN, Hlushchuk R, Djonov VG. Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling. Angiogenesis 2009;12:113–23.

[102] Djonov V, Baum O, Burri PH. Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res 2003;314:107–17.

[103] Blanco R, Gerhardt H. VEGF and Notch in tip and stalk cell selection. Cold Spring Harb Perspect Med 2013;3:a006569.

[104] Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003;161:1163–77.

[105] Tymko MM, Lawley JS, Ainslie PN, et al. Global Reach 2018 Heightened alpha-Adrenergic Signaling Impairs Endothelial Function During Chronic Exposure to Hypobaric Hypoxia. Circ Res 2020;127:e1–e13.

[106] Swenson ER. Sympathetic nervous system activation and vascular endothelial function with chronic hypoxia. Circ Res 2020;127:247–8.

[107] Ungvari Z, Tarantini S, Kiss T, et al. Endothelial dysfunction and angiogenesis impairment in the ageing vasculature. Nat Rev Cardiol 2018;15:555–65.

[108] Chen HI, Li HT, Chen CC. Physical conditioning decreases norepinephrine- induced vasoconstriction in rabbits. Possible roles of norepinephrine-evoked endothelium-derived relaxing factor. Circulation 1994;90:970–5.

[109] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science 2020;367:eaau6977.

[110] Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 1983;97:329–39.

[111] Pan BT, Teng K, Wu C, et al. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 1985;101:942–8.

[112] Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183:1161–72.

[113] Huang-Doran I, Zhang CY, Vidal-Puig A, et al. Extracellular vesicles: novel mediators of cell communication in metabolic disease. Trends Endocrinol Metab 2017;28:3–18.

[114] Gurunathan S, Kang MH, Jeyaraj M, et al. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells 2019;8:307.

[115] Takahashi A, Okada R, Nagao K, et al. Exosomes maintain cellular homeostasis by excreting harmful DNA from cells. Nat Commun 2017;8:15287.

[116] Mathieu M, Martin-Jaular L, Lavieu G, et al. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol 2019;21:9–17.

[117] Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002;2:569–79.

[118] Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem 2019;88:487–514.

[119] Liu J, Ren L, Li S, et al. The biology, function, and applications of exosomes in cancer. Acta Pharm Sin B 2021;11:2783–97.

[120] van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 2018;19:213–28.

[121] McAndrews KM, Kalluri R. Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer 2019;18:52.

[122] Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018;7:1535750.

[123] Shah R, Patel T, Freedman JE. Circulating extracellular vesicles in human disease. N Engl J Med 2018;379:958–66.

[124] Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011;29:341–5.

[125] Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 2017;546:498–503.

[126] Wang Q, Yu J, Kadungure T, et al. ARMMs as a versatile platform for intracellular delivery of macromolecules. Nat Commun 2018;9:960.

[127] Taraboletti G, D’Ascenzo S, Borsotti P, et al. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 2002;160:673–80.

[128] Critser PJ, Yoder MC. Endothelial colony-forming cell role in neoangiogenesis and tissue repair. Curr Opin Organ Transplant 2010;15:68–72.

[129] Deregibus MC, Cantaluppi V, Calogero R, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007;110:2440–8.

[130] Giricz Z, Varga ZV, Baranyai T, et al. Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol 2014;68:75–8.

[131] Femmino S, Penna C, Margarita S, et al. Extracellular vesicles and cardiovascular system: biomarkers and Cardioprotective Effectors. Vascul Pharmacol 2020;135:106790.

[132] Potz BA, Scrimgeour LA, Pavlov VI, et al. Extracellular vesicle injection improves myocardial function and increases angiogenesis in a swine model of chronic ischemia. J Am Heart Assoc 2018;7:e008344.

[133] Cantaluppi V, Gatti S, Medica D, et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int 2012;82:412–27.

[134] Zhang J, Chen C, Hu B, et al. Exosomes derived from human endothelial progenitor cells accelerate cutaneous wound healing by promoting angiogenesis through Erk1/2 signaling. Int J Biol Sci 2016;12:1472–87.

[135] Zhuang Y, Cheng M, Li M, et al. Small extracellular vesicles derived from hypoxic mesenchymal stem cells promote vascularized bone regeneration through the miR-210-3p/EFNA3/PI3K pathway. Acta Biomater 2022;150:413–26.

[136] Liu L, Zheng CX, Zhao N, et al. Mesenchymal stem cell aggregationreleased extracellular vesicles induce CD31(+) EMCN(+) vessels in skin regeneration and improve diabetic wound healing. Adv Healthc Mater 2023;12:e2300019.

[137] Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 1987;20:263–72.

[138] Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 1988;136:42–60.

[139] Samsonraj RM, Raghunath M, Nurcombe V, et al. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med 2017;6:2173–85.

[140] Timmers L, Lim SK, Arslan F, et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 2007;1:129–37.

[141] van Koppen A, Joles JA, van Balkom BW, et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One 2012;7:e38746.

[142] Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010;4:214–22.

[143] Ono M, Kosaka N, Tominaga N, et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signaling 2014;7:ra63.

[144] Phinney DG, Di Giuseppe M, Njah J, et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun 2015;6:8472.

[145] Rani S, Ryan AE, Griffin MD, et al. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther 2015;23:812–23.

[146] Eirin A, Zhu XY, Puranik AS, et al. Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation. Kidney Int 2017;92:114–24.

[147] Haga H, Yan IK, Takahashi K, et al. Extracellular vesicles from bone marrow-derived mesenchymal stem cells improve survival from lethal hepatic failure in mice. Stem Cells Transl Med 2017;6:1262–72.

[148] Li L, Zhang Y, Mu J, et al. Transplantation of human mesenchymal stem-cell-derived exosomes immobilized in an adhesive hydrogel for effective treatment of spinal cord injury. Nano Lett 2020;20:4298–305.

[149] Liu W, Li L, Rong Y, et al. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater 2020;103:196–212.

[150] Tao SC, Yuan T, Zhang YL, et al. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics 2017;7:180–95.

[151] Kishore R, Khan M. More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair. Circ Res 2016;118:330–43.

[152] Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release 2015;207:18–30.

[153] Yu M, Liu W, Li J, et al. Exosomes derived from atorvastatin- pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway. Stem Cell Res Ther 2020;11:350.

[154] Fatima F, Ekstrom K, Nazarenko I, et al. Non-coding RNAs in mesenchymal stem cell-derived extracellular vesicles: deciphering regulatory roles in stem cell potency, inflammatory resolve, and tissue regeneration. Front Genet 2017;8:161.

[155] Teng X, Chen L, Chen W, et al. Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation. Cell Physiol Biochem 2015;37:2415–24.

[156] Zhang HC, Liu XB, Huang S, et al. Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev 2012;21:3289–97.

[157] Zou X, Gu D, Xing X, et al. Human mesenchymal stromal cell-derived extracellular vesicles alleviate renal ischemic reperfusion injury and enhance angiogenesis in rats. Am J Transl Res 2016;8:4289–99.

[158] Ma J, Zhao Y, Sun L, et al. Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D. Stem Cells Transl Med 2017;6:51–9.

[159] Wu M, Liu X, Li Z, et al. SHED aggregate exosomes shuttled miR-26a promote angiogenesis in pulp regeneration via TGF-beta/SMAD2/3 signalling. Cell Prolif 2021;54:e13074.

[160] Chen S, Tang Y, Liu Y, et al. Exosomes derived from miR-375-overexpressing human adipose mesenchymal stem cells promote bone regeneration. Cell Prolif 2019;52:e12669.

[161] Li W, Liu Y, Zhang P, et al. Tissue-engineered bone immobilized with human adipose stem cells-derived exosomes promotes bone regeneration. ACS Appl Mater Interfaces 2018;10:5240–54.

[162] Li X, Zheng Y, Hou L, et al. Exosomes derived from maxillary BMSCs enhanced the osteogenesis in iliac BMSCs. Oral Dis 2020;26:131–44.

[163] Qi X, Zhang J, Yuan H, et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and Osteogenesis in Osteoporotic rats. Int J Biol Sci 2016;12:836–49.

[164] Liao W, Ning Y, Xu HJ, et al. BMSC-derived exosomes carrying microRNA-122-5p promote proliferation of osteoblasts in osteonecrosis of the femoral head. Clin Sci 2019;133:1955–75.

[165] Zhang L, Jiao G, Ren S, et al. Exosomes from bone marrow mesenchymal stem cells enhance fracture healing through the promotion of osteogenesis and angiogenesis in a rat model of nonunion. Stem Cell Res Ther 2020;11:38.

[166] Zhang J, Liu X, Li H, et al. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res Ther 2016;7:136.

[167] Lu Z, Chen Y, Dunstan C, et al. Priming adipose stem cells with tumor necrosis factor-alpha preconditioning potentiates their exosome efficacy for bone regeneration. Tissue Eng Part A 2017;23:1212–20.

[168] Zhu Q, Heon M, Zhao Z, et al. Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics. Lab Chip 2018;18:1690–703.

[169] Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 2010;18:1606–14.

[170] Pascucci L, Cocce V, Bonomi A, et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release 2014;192:262–70.

[171] Kim MS, Haney MJ, Zhao Y, et al. Development of exosome- encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 2016;12:655–64.

[172] Fuhrmann G, Serio A, Mazo M, et al. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release 2015;205:35–44.

[173] Sato YT, Umezaki K, Sawada S, et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep 2016;6:21933.

RIGHTS & PERMISSIONS

The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.